Ikaika Therapeutics
PrivateLast Round
VC Round
Oct 7, 2021
Company Overview
Ikaika Therapeutics is a biotechnology company that develops first-in-class antibody therapies to prevent fibrosis and preserve organ function in patients with muscular dystrophy and other fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ikaika Therapeutics Comparables
Compare Ikaika Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tribune Therapeutics | 77% | |
| Bristol Myers Squibb | 74% | |
| Mediar Therapeutics | 72% |
Ikaika Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 7, 2021 |
Ikaika Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Qral Ventures | VC Round |
Ikaika Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ikaika Therapeutics's valuation, stock price, and market status.
Is Ikaika Therapeutics a public or private company?
Ikaika Therapeutics is a private company.
What is the current stock price of Ikaika Therapeutics?
Ikaika Therapeutics is a private company with no public stock price. Caplight tracks Ikaika Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Ikaika Therapeutics worth (valuation)?
Valuation information for Ikaika Therapeutics is not publicly available.
Can I buy Ikaika Therapeutics stock?
Ikaika Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ikaika Therapeutics's last funding round?
Ikaika Therapeutics's most recent funding round was VC Round on October 7, 2021.
Who are the main investors in Ikaika Therapeutics?
Key investors in Ikaika Therapeutics include Qral Ventures.
Will Ikaika Therapeutics IPO soon?
No public IPO plans have been announced for Ikaika Therapeutics.
How can I track Ikaika Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ikaika Therapeutics's secondary market activity and sign up for updates.